Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
Point-of-care PCR testing for STIs in the ED reduced length of stay and improved antibiotic stewardship compared with central laboratory testing.
News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
A landmark study, titled “How error correction affects polymerase chain reaction deduplication: A survey based on unique molecular identifier datasets of short reads” recently published in ...
Amerigo Scientific launches its isothermal amplification instrument range to overcome the limitations of current nucleic acid amplification technologies.
Medical Device Network on MSN
Fulgent Genetics to buy Bako Diagnostics assets and StrataDx
Fulgent Genetics has signed a definitive agreement to buy specific assets of Bako Diagnostics and to acquire StrataDx, two US-based laboratories, for a combined purchase price of around $55.5m.
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback